Andere talen Bioretec Oy

Aandelen

BRETEC

FI4000480454

Beurs gesloten - Nasdaq Helsinki Andere beurzen 17:15:37 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,69 ^EUR	+0,37%		+1,51%	+12,08%

21/05	Bedrijf in medische apparatuur Bioretec benoemt nieuwe CEO	MT
05/04	Bioretec Oy kondigt aan dat Pekka Simula niet beschikbaar is voor herverkiezing tot lid van de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings - Ilmarinen Mutual Pension Insurance Company	21/05
Medical Device Company Bioretec Names New CEO	21/05
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (Stephen Industries Inc Oy)	20/05
Inside information: Alan Donze has been appointed as Bioretec's new CEO	20/05
Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses	16/05
Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors	26/04
Notice of Annual General Meeting (AGM) of Bioretec Ltd	08/04
Notice of Annual General Meeting (AGM) of Bioretec Ltd	05/04
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	05/04
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	22/03
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office	21/03
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	21/03
Bioretec Ltd's Annual Report and Financial Statements 2023 published	15/03
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	14/03
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage	14/03
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	14/03
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	11/03
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	08/03
Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory	16/02
Bioretec and Stephen Industries donate medical devices to Ukraine	08/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bioretec Oy

Aandelen

BRETEC

FI4000480454

Andere talen

Filters